Introduction
============

Chronic hepatitis B Virus (HBV) infection is defined as either existence of HBsAg in someone\'s blood who tests negative for IgM antibodies against hepatitis B core antigen (IgM anti-HBc), or existence of HBsAg in blood serum for at least 6 months ([@B1]). Despite availability of an efficient vaccine and powerful antiviral treatments, chronic HBV infection has remained one the most important public health concerns and a major cause of deaths from cirrhosis and liver malignancy worldwide ([@B2]-[@B6]). HBV is highly contagious and transmitted mainly via blood transfusion, unsafe injection practices, sexual contact, and mother-to-child transmission ([@B7]).

An important international study showed that global HBsAg sero-prevalence is 3.61%, with the highest prevalence rate in African countries (8.83%) and Western Pacific region (5.26%), respectively. This study showed that nearly 248 million people were HBsAg positive in 2010 ([@B3]). In a meta-analysis in 2016, the pooled prevalence of HBV infection among general population in Iran was 2.2% ([@B5]).

Global Burden of Disease, Mortality, and Causes of Death Collaborators estimate that HBV is one of first causes of mortality worldwide, accounting for 686,000 (520,000-866000) deaths annually. Age standardized death rate of HBV equals to 1.1 (95% CI: 0.8-1.3) case per 100,000 persons ([@B6]).

HBV is transmitted mainly by percutaneous or mucosal contact with infected blood or other body fluids ([@B2]). Therefore, some specific populations including prison inmates, injection drug users (IDUs), addict persons, and female sex workers (FSWs) are at higher risk of HBV infection ([@B8]-[@B11]). Consequently, having information about prevalence of HBV among high risk groups has been a concern to public health policy- makers and service providers. Policy-makers can use this information to effectively allocate resources and healthcare activities to truly needy population groups. On the other hand, accurate data about prevalence of HBV infection among different sub-groups of population, especially high risk groups, is vital to evaluate impacts of prevention programs, including vaccination and educational programs, and also to determine the burden of the disease. Although many studies have been carried out about HBV sero-prevalence in other countries, there is no comprehensive data regarding prevalence of HBV infection among Iranian high risk groups. Therefore, this study aimed to determine prevalence of HBV infection among Iranian high risk groups by conducting an up-to-date systematic review and meta-analysis.

Methods
=======

**Search Strategy**

We utilized PRISMA statement as a guide to enhance quality of the review ([@B12]). Major international electronic bibliographic databases, including PubMed, Scopus and Web of Science and National databases including Magiran, Iranmedex, and SID, were searched from 2000 to 2016. In addition, reference lists of relevant studies were searched manually.

The following terms were used to search the international databases; ''prostitute''; ''FSW'' or ''sex worker''; ''intravenous drug users''; ''drug addicts''; ''IDU'' or ''injection drug users''; ''prisoner''; ''jail''; ''inmate'' or ''prison''; and ''HBV'' or ''Hepatitis B'' or ''blood borne infection'' and ''Iran''. The searching was restricted to studies in English conducted since 2000 and afterwards.

Sex work was defined as exchange of sex for money, drugs, or goods ([@B13]). Also, IDUs were defined as people who inject narcotic substances into the body with a hollow needle and a syringe which is pierced through the skin into the body usually intravenously ([@B14]). Only the articles that determined HBV infection in patients by laboratory criteria, according to national guidelines, were included into the review ([@B4]).

**Data Extraction and Quality Assessment**

Two independent authors (YM and KM) reviewed the retrieved studies from initial search by Title/ Abstract. For the studies that was eligible for meta-analysis, the following information were extracted: (1) name of the first author, (2) publication year and location of study conduction, (3) total sample size, (4) the reported prevalence of infection, (5) recruitment setting, (6) recruitment method, (7) age group and (7) high risk group (IDUs, FSWs, or prisoners). The kappa statistics (95%) was used to identify the inter-authors reliability. The third author (AA) was considered as arbiter to resolve any disagreements. The STROBE statement was used to assess the quality of studies.

**Statistical analysis**

At first, the variance of each study was calculated through the variance of a binomial distribution, given that the prevalence rate has a binomial distribution. Then, each study was given a weight, which was inversely proportional to the variance.

The heterogeneity of results across studies was controlled for using chi-square (Chi2) test (with P-value \<0.10) and I^2^ statistic. The I^2^ statistic greater than 75% was considered as indicator of significant heterogeneity across studies. Subgroups analysis was conducted on the basis of infection type, high risk group, and geographical regions. Meta regression was used to examine the impact of year of study on prevalence rate of HBV among prisoners and IDUs.

Random-effects meta-analysis model was used to pool the estimated prevalence of HBV from retrieved studies. All the analyses were performed using Stata software version 12 (Stata Corp, College Station, TX, USA) by the "metan"([@B15]), "metareg"([@B16]), "metabias"([@B17]), "metacum"([@B18]) and "metainf" ([@B19]) commands.
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Results
=======

[Figure 1](#F1){ref-type="fig"} shows the results of the literature review and selection process. A total of 911 potentially relevant articles were identified from the initial literature review. After removing duplicates, 566 articles remained and then the authors excluded other 489 articles by screening the titles and abstracts. Finally 37studies met eligibility criteria for meta-analysis that included 22057 HBV positive patients.

**Study Characteristics**

Full characteristics of primary included studies are shown in [Table 1](#T1){ref-type="table"}. These studies were published between 2003 and 2015. The sample size of included articles varied from 60 to 8630, with a total of 22057 cases with high risk behaviors, including FWS (2 studies), IDUs (19 studies), prisoners (13 studies) and drug addicts (2 studies). The lowest prevalence rate was reported by Teimori *et al.* in Kermanshah among IDUs (0 %) and the highest prevalence rate was reported by Amin-Esmaeili *et al*. among IDUs in Tehran (24.7%).

**Evaluation of Heterogeneity and Meta-Analysis**

Results of Cochran's Q test and I^2^ statistics indicated of significant heterogeneity among the included studies (Q=496.13, df =36, p\<0.001 and I^2^=92.74%). The pooled prevalence of HBV infection in high risk groups was 4.8% (95% CI: 3.6%-6.1%). In order to reduce the heterogeneity, the authors conducted a subgroup analysis based on geographical regions ([Table 2](#T2){ref-type="table"}). Accordingly, the prevalence of HBV among high risk groups in north, west, southwest, east, northeast, and central regions of Iran was 7 (95% CI: 4.0-11.0), 3 (95% CI: 1.0, 6.0), 5 (95% CI: 3.0-7.0) and 5% (95% CI: 3.1, 7.3), respectively.

**Meta Regression**

Results of meta-regression analysis are shown in [Fig 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}. According to the findings, prevalence of HBsAg among prisoners was not related to year of study and its decreasing trend over the years was not significant (*P*=0.72). In addition, increasing trend of HBV prevalence among IDUs over the years was not significant also (*P*=0.4).

**Sensitivity Analysis**

Sensitivity analysis showed that exclusion of individual studies could not substantially change the results. The pooled prevalence of HBsAg positive ranged from 4.47%, 95% CI: 3.12-5.8 (when excluding Mardani *et al.*([@B21]) to 5.97%, 95% CI: 4.28-7.66 (when excluding Soud bakhsh *et al*. ([@B41]).

**Cumulative Meta-Analysis**

As shown in [figure 2](#F1){ref-type="fig"}, cumulative meta-analysis of HBs Ag positive based on publication year, revealed that the overall prevalence estimates were constant in high risk groups and that the 95% CIs narrowed with accumulation of primary study data over time.

Discussion
==========

Despite availability of an effective vaccine against hepatitis B since early 1990s, covering more than 400 million people, the disease remains a major public health problem throughout the world ([@B54]). People at elevated risk of HBV infection are a key group that should be specifically targeted for prevention and control measures ([@B55]). For such attempts, to be properly scaled, targeted, having updated, detailed, and accurate data about the high risk populations is a prerequisite.

Our systematic review showed that the overall prevalence of HBV infection among high-risk groups in Iran is nearly 4.8%, with clear geographical differences across the country. More specifically, the prevalence of HCV infection was the highest in northern parts of the country (prevalence proportion of 7% in Gorgan, Sari and Ghaemshahr). On the other hand, this proportion was lowest in west and southwest of Iran (prevalence proportion of 3% in Hamadan, Kermanshah, Zanjan, and Ahvaz). As well, results showed that year of study can lead to heterogeneity in estimated prevalence of HBV infection IDUs and prisoners.

###### 

Description of the studies included in the meta-analysis

  First author/year (Ref)                 Sample size   Location                         High risk group        Recruitment setting               Recruitment method           Age group      Gender
  --------------------------------------- ------------- -------------------------------- ---------------------- --------------------------------- ---------------------------- -------------- --------
  Ghasemian et al. (2011) ([@B20])        88            Sari, Ghaemshahr                 IDU                    Hospital                          Census                       35.01±11.53    Both
  Ziaei et al. (2014) ([@B8])             881           Southern Khorasan                Prisoner               Prison                            random sampling              34.7 ±11.4     Both
  Mardani et al. (2006) ([@B21])          808           Qom                              Prisoner               Prison                            Census                       Mean=35        Both
  Naderi et al. (2004) ([@B22])           144           Tehran                           IDU                    Hospital                          Census                       26-30          Both
  Zamani et al. (2010) ([@B23])           118           Isfahan                          IDU                    Community                         peer-driven sampling         29.0 ±6.6      Both
  Paridar et al. (2009) ([@B24])          600           Shahr kord                       Prisoner               Prison                            Census                       NA             Both
  Amin-Esmaeili et al. (2012) ([@B25])    899           Tehran                           IDU                    drug treatment centers            purposive sampling           33.9 ±9.4      Both
  Saleh et al. (2007) ([@B26])            94            Hamadan                          IDU                    Forensic medicine                 Census                       NA             Both
  Khodabakhshi et al. (2007) ([@B27])     121           Gorgan                           drug addict prisoner   Prison                            random sampling              NA             Both
  Mohamadkhani et al. (2010) ([@B28])     220           Tehran                           IDU                    MMT center                        Census                       NA             Both
  Tavakkoli et al. (2008) ([@B29])        518           Tehran                           IDU                    Combined                          volunteers                   NA             Both
  Azarkar et al. (2006) ([@B30])          400           Birjand                          Prisoner               Prison                            Stratified random sampling   34.1±11.7      Both
  Sharif et al. (2009) ([@B31])           200           Kashan                           IDU                    Hospitalized                      volunteers                   36.5 ± 10.2    Both
  Alavi et al. (2010) ([@B32])            142           Ahvaz                            IDU                    Hospitalized                      NA                           26.3±5.7       Both
  Majidi et al. (2012) ([@B33])           104           Tehran                           IDU                    Hospital                          NA                           NA             Both
  Ghorbani et al. (2007) ([@B34])         139           Sabzevar                         Prisoner               prison                            NA                           NA             Both
  Asghari et al. (2009) ([@B35])          8630          10 Province                      Prisoner               Prison                            volunteers                   NA             Both
  Imani et al. (2008) ([@B36])            133           Shahre kourd                     IDU                    voluntary rehabilitation center   Census                       31.3±7.1       Both
  Ghanbarzadeh et al. (2006) ([@B37])     199           Birjand                          Prisoner               Prison                            volunteers                   35±12.3        Female
  Teimori et al. (2012) ([@B38])          76            Kermanshah                       IDU                    MMT center                        Convenience sampling         35.2±0.99      Female
  Nokhodian et al. (2012) ([@B39])        161           Isfahan                          Prisoner               Prison                            Census                       34.54 ± 11.2   Female
  Moayedi-Nia et al. (2015) ([@B40])      161           Tehran                           FSW                    NA                                respondent driven sampling   37.43 ± 8.9    Female
  Soudbakhsh et al. (2007) ([@B41])       60            Tehran                           IDU                    Hospital                          Census                       35.3±9.68      Male
  Taeri et al. (2007) ([@B42])            106           Isfahan                          IDU                    Hospital                          volunteers                   50.8±8.1       Male
  Amin-Zadeh et al. (2007) ([@B43])       70            Tehran                           IDU                    Hospital                          volunteers                   34.4±9.6       Male
  Alasvand et al. (2015) ([@B44])         2120          6 Province                       Prisoner               prison                            random sampling              37±13          Male
  Rowhani Rahbar et al. (2004) ([@B45])   101           Mashhad                          IDU                    Prison                            convenience sample           32.8           Male
  SeyedAlinaghi et al. (2010) ([@B46])    452           Tehran                           Prisoner               Prison                            volunteers                   NA             Male
  Ramezani et al. (2014) ([@B9])          100           Arak                             IDU                    MMT center                        Census                       17-58          Male
  Pourahmad et al. (2007) ([@B47])        1431          Isfahan, Lorestan Chaharmahal,   Prisoner               Prison                            NA                           25-60          Male
  Sofian et al. (2012) ([@B48])           153           Arak                             Prisoner               Prison                            Census                       30.7 ±5.9      Male
  Nokhodian et al. (2014) ([@B10])        970           Isfahan                          Prisoner               Prison                            volunteers                   32.61 ± 8.1    Male
  Meshkati et al. (2007) ([@B49])         98            Isfahan                          IDU                    Behavioral consulting canter      Census                       30- 40         Male
  Khani et al. (2003) ([@B50])            346           Zanjan                           drug addict prisoner   Prison                            NA                           33.7 ± 10.2    Male
  Daneshmand et al. (2013) ([@B51])       970           Isfahan                          IDU                    Prison                            Census                       36.6±0.31      Male
  Khosravani et al. (2012) ([@B52])       153           Kohgiloyeh & Boyerahmad          IDU                    Community                         Census                       34.9           Both
  Kassaian et al. (2011) ([@B53])         91            Isfahan                          FSW                    DIC                               Snowball sampling            30.84±9.34     Female

###### 

Meta-analysis of prevalence of HBV infection based on high risk groups in different geographic area of Iran

  ---------------------------------------------------------------------------------------------------------------------------------------------
  Geographic location   N of study (sample size)   Prisoners\       IDUs\            FSWs\            Drug addict prisoners\   Overall\
                                                   prevalence (%)   prevalence (%)   prevalence (%)   prevalence (%)           prevalence (%)
  --------------------- -------------------------- ---------------- ---------------- ---------------- ------------------------ ----------------
  2 (209)               \-                         13 (6, 21)       \-                                4 (1, 9)                 7 (4, 11)

  4 (658)               \-                         2 (0, 7)         \-                                4 (2, 6)                 3 (1, 6)

  5 (1841)              5 (3, 8)                   3 (1, 8)         \-                                \-                       5 (3, 7)

  24 (8720)             5.2 (2.7, 8.3)             5.2 (2.2, 9.3)   3.3 (1.3, 6)                      \-                       5 (3.1, 7.3)
  ---------------------------------------------------------------------------------------------------------------------------------------------
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In 2009, Poorolajal *et al*. ([@B56]), reported of an estimated rate of 3.2% HBV infection among Iranian high risk groups. However their review covered only 4 studies ([@B8], [@B29], [@B57], [@B58]) on IDUs from 2001 to 2003. Unfortunately, there has been no comprehensive systematic review of HBV prevalence in high risk population in Iran since then. To estimate HBV infection prevalence among Iranian high risk groups, an extensive literature review spanning from 2003 to 2015 was carried out in the present study. The results of our systematic review revealed that the estimated prevalence of HBV infection among Iranian high risk population was 4.8 % (95% CI: 3.6%-6.1%), a rate which is over two times higher than HBV prevalence among the general population of Iran (2.2%) ([@B5]).

Significant reduction in prevalence of HBV infection is expected to occur with implementation of national vaccination programs and other preventive measures. A recent systematic review by Salehi-Vaziri *et al.* ([@B5]) revealed a substantial reduction of HBV infection among general population of Iran. The estimated rate of HBV infection before 2010 was 2.9%, while the rate was 1.3% in 2010 and onwards ([@B5]). In the present study, however the cumulative meta-analysis revealed that the prevalence of HBV infection was constant over the time among Iranian high risk groups.

This observation can be explained by two reasons: 1) the fact that the majority of study population was born before 1993, the year when infant HBV vaccination was launched in the country, and 2) potential low efficacy of HBV immunization, in case if they received HBV vaccine, which has been documented by several reports ([@B59]-[@B63]).

Our review revealed a significant heterogeneity in prevalence of HBV infection among high risk groups from different geographical areas of Iran. Analysis of HBV prevalence within 4 geographical categories of north, west/southwest, east/northeast, and center showed the highest prevalence in north (7%) and the lowest in west/southwest regions (3%). The heterogeneity in geographical distribution of HBV infection was also indicated by two previous systematic reviews on general population in Iran. Therefore, it could be suggested that risk factors of HBV infections may be different across various regions of Iran and further studies on social, cultural, structural and behavioral factors affecting HBV infection in different parts of the country are clearly needed ([@B5], [@B64]). Nevertheless, there is a paucity of knowledge about the prevalence of HBV in many provinces of Iran, as the studies included in the present review hardly covered half of all provinces of Iran. To fill this gap, an active surveillance system should be established to monitor the burden of HBV among high risk groups throughout the country.

Given that HBV is a sexually transmitted infection, sex workers are at elevated risk of contracting the virus. It is estimated that sexual contact is the mode of infection transmission in nearly 50% of HBV cases among American young adults ([@B65]). However, there is a huge lack of knowledge not only about the rate of HBV infection, but also on other sexually transmitted infections (STIs) in Iran ([@B66]). This review highlights the lack of enough knowledge on prevalence of HBV among sex workers in Iran. Given that implementation of educational programs about sexual issues cannot be scaled up in Iran, due to some specific cultural features of Iranian society ([@B66]), monitoring of this high risk group is a matter of great importance in order to decrease the burden of HBV infection.

Previous reviews on general population of Iran indicated higher prevalence rate of HBV infection among men ([@B5], [@B64]). However, the authors were not able to estimate the prevalence of the infection based on gender in the present study, as almost all publications included in the current review were conducted exclusively on men. Although risk factors are more common in men, women should also be evaluated in terms of HBV infection and its risk factors in the country, especially in light of the fact that the number of women with high risk activities is increasing in Iran.

Our results indicate that prevalence of HBV infection among high risk groups was seemingly high in Iran. Health policy decision-makers should be aware of prevalence of HBV infection among different high risk groups and in different regions of Iran.
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